disease & medicine, techniques

The National Academies’ report touches on ethical issues raised by new technologies such as brain organoids and human-animal chimeras, and suggests that current regulatory oversight is sufficient.

Following on the success of CAR T cells used to treat cancers of the blood, researchers have launched a Phase 1 clinical trial of genetically modified macrophages to target solid tumors.

A noninvasive saliva test accurately identified concussions in a study of hundreds of rugby players.

Sam Wilson discusses a user-friendly set of resources that he and his collaborators developed to aid labs pivoting to study COVID-19.

Engineered viruses that don’t replicate provide a tractable model for scientists to safely study SARS-CoV-2, including research into vaccine efficacy and emerging variants.

The Cardiff University researcher was famous both for his work on genetic disorders and for his documentation of the history of his field.

The Rutgers University researcher created the first FDA-authorized spit test, which has since been used by millions of people.

DNA replication errors during cell division cause monozygotic twins to diverge from each other even during the earliest stages of development, a new study finds.

The identification of the transcription factors that elicit oocyte growth will aid reproductive biology research and might help women with fertility issues, scientists say.  

The technology solves proteins’ 3-D shapes in minutes, when traditional methods may take years.

In a first-of-its-kind study, researchers monitored subsecond changes in levels of the neurotransmitters in the human brain, unlocking new insight into their function.

The effects seem to be mediated by a reactive oxygen species in the animals’ livers.

From hospitals and college campuses to remote villages in French Guiana, scientists have pit the two approaches against one other. See which one comes out ahead.

The University of Oregon scientist studied the structure and function of chromatin, with the intent of designing new therapeutic tools.

Almost 60 percent of people in a new study on attitudes in the US felt comfortable using animals to grow human organs from induced pluripotent stem cells.

A small study shows artificial intelligence can pick out individuals with coronavirus infections, but ophthalmologists and AI experts say the approach is far from proven to be capable of distinguishing infections with SARS-CoV-2 from other ills.

SalivaDirect, an open-source protocol, avoids many of the supply bottlenecks of other tools and could be offered for as little as $10 a test.